glycine has been researched along with Angiitis in 4 studies
| Excerpt | Relevance | Reference |
|---|---|---|
| "We investigated the efficacy of sivelestat sodium hydrate (SSH) as a treatment for Kawasaki disease, and its pharmacological action sites, in mice with Candida albicans water-soluble fraction-induced vasculitis." | 8.12 | Sivelestat's effect on Candida albicans water-soluble fraction-induced vasculitis. ( Banno-Terada, R; Endo, M; Fujii, T; Kohno, T; Maekawa, A; Mamiya, R; Nagi-Miura, N; Ohno, N; Takada, M; Takagaki, N; Tanaka, A; Tsuji, T; Yamada, A; Yoshida, Y, 2022) |
| "Ixazomib is a second-generation proteasome inhibitor that has been approved in the combination treatment of multiple myeloma and is currently under clinical investigation for the management of Waldenstrom's macroglobulinemia." | 5.48 | Ixazomib-induced cutaneous necrotizing vasculitis. ( Alloo, A; Castillo, JJ; Granter, SR; Jadeja, SM; Khosravi, H; LeBoeuf, NR; Richardson, PG, 2018) |
| "We investigated the efficacy of sivelestat sodium hydrate (SSH) as a treatment for Kawasaki disease, and its pharmacological action sites, in mice with Candida albicans water-soluble fraction-induced vasculitis." | 4.12 | Sivelestat's effect on Candida albicans water-soluble fraction-induced vasculitis. ( Banno-Terada, R; Endo, M; Fujii, T; Kohno, T; Maekawa, A; Mamiya, R; Nagi-Miura, N; Ohno, N; Takada, M; Takagaki, N; Tanaka, A; Tsuji, T; Yamada, A; Yoshida, Y, 2022) |
| "Ixazomib is a second-generation proteasome inhibitor that has been approved in the combination treatment of multiple myeloma and is currently under clinical investigation for the management of Waldenstrom's macroglobulinemia." | 1.48 | Ixazomib-induced cutaneous necrotizing vasculitis. ( Alloo, A; Castillo, JJ; Granter, SR; Jadeja, SM; Khosravi, H; LeBoeuf, NR; Richardson, PG, 2018) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (50.00) | 24.3611 |
| 2020's | 2 (50.00) | 2.80 |
| Authors | Studies |
|---|---|
| Yoshida, Y | 1 |
| Banno-Terada, R | 1 |
| Takada, M | 1 |
| Fujii, T | 1 |
| Takagaki, N | 1 |
| Maekawa, A | 1 |
| Tanaka, A | 1 |
| Endo, M | 1 |
| Yamada, A | 1 |
| Mamiya, R | 1 |
| Nagi-Miura, N | 1 |
| Ohno, N | 1 |
| Tsuji, T | 1 |
| Kohno, T | 1 |
| Kawagashira, Y | 1 |
| Koike, H | 1 |
| Kawabata, K | 1 |
| Takahashi, M | 1 |
| Ohyama, K | 1 |
| Hashimoto, R | 1 |
| Iijima, M | 1 |
| Katsuno, M | 1 |
| Sobue, G | 1 |
| Alloo, A | 1 |
| Khosravi, H | 1 |
| Granter, SR | 1 |
| Jadeja, SM | 1 |
| Richardson, PG | 1 |
| Castillo, JJ | 1 |
| LeBoeuf, NR | 1 |
| McCabe, P | 1 |
| Agarwal, N | 1 |
| Johnson, R | 1 |
4 other studies available for glycine and Angiitis
| Article | Year |
|---|---|
Sivelestat's effect on Candida albicans water-soluble fraction-induced vasculitis.
Topics: Animals; Candida albicans; Glycine; Humans; Intercellular Adhesion Molecule-1; Mice; Mucocutaneous L | 2022 |
Vasculitic Neuropathy Following Exposure to a Glyphosate-based Herbicide.
Topics: Aged; Glycine; Glyphosate; Herbicides; Humans; Male; Peripheral Nervous System Diseases; Vasculitis | 2017 |
Ixazomib-induced cutaneous necrotizing vasculitis.
Topics: Aged, 80 and over; Boron Compounds; Glycine; Humans; Male; Proteasome Inhibitors; Vasculitis | 2018 |
Small Bowel Ulcers From Cryocrystalglobulinemia.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Boron Compounds; Bortezomib; Cryoglobulinemia | 2020 |